Comparison of the pharmacokinetics of cyclosporine Sandimmune with Sandimmune Neoral in stable renal transplant patients. 1994

I S Sketris, and J G Lawen, and L Beauregard-Zollinger, and P Belitsky, and D Landsberg, and M L Givner, and P Keown
Multiorgan Transplant Program, Victoria General Hospital, Halifax, Nova Scotia, Canada.

UI MeSH Term Description Entries
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses

Related Publications

I S Sketris, and J G Lawen, and L Beauregard-Zollinger, and P Belitsky, and D Landsberg, and M L Givner, and P Keown
August 1996, Transplantation proceedings,
I S Sketris, and J G Lawen, and L Beauregard-Zollinger, and P Belitsky, and D Landsberg, and M L Givner, and P Keown
January 1997, Transplantation proceedings,
I S Sketris, and J G Lawen, and L Beauregard-Zollinger, and P Belitsky, and D Landsberg, and M L Givner, and P Keown
January 2001, Transplantation proceedings,
I S Sketris, and J G Lawen, and L Beauregard-Zollinger, and P Belitsky, and D Landsberg, and M L Givner, and P Keown
August 1998, Transplantation proceedings,
I S Sketris, and J G Lawen, and L Beauregard-Zollinger, and P Belitsky, and D Landsberg, and M L Givner, and P Keown
December 1996, Transplantation proceedings,
I S Sketris, and J G Lawen, and L Beauregard-Zollinger, and P Belitsky, and D Landsberg, and M L Givner, and P Keown
March 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
I S Sketris, and J G Lawen, and L Beauregard-Zollinger, and P Belitsky, and D Landsberg, and M L Givner, and P Keown
April 1995, Transplantation proceedings,
I S Sketris, and J G Lawen, and L Beauregard-Zollinger, and P Belitsky, and D Landsberg, and M L Givner, and P Keown
August 1996, Transplantation proceedings,
I S Sketris, and J G Lawen, and L Beauregard-Zollinger, and P Belitsky, and D Landsberg, and M L Givner, and P Keown
January 1999, Clinical therapeutics,
I S Sketris, and J G Lawen, and L Beauregard-Zollinger, and P Belitsky, and D Landsberg, and M L Givner, and P Keown
November 2000, Transplantation proceedings,
Copied contents to your clipboard!